免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

臨床試驗

SALVAGE Trial (Safety And cLinical Value of AutoloGous rEinfusion)

NCT:NCT07712666 · NOT_YET_RECRUITING

NCT IDNCT07712666
狀態NOT_YET_RECRUITING
開始日期2026-11-01
完成時間2029-08-01
SponsorMayo Clinic (OTHER)
First posted
Last updated

簡要摘要

The investigator hypothesizes intraoperative salvaged red blood cells are a poor substitute for allogenic packed red blood cell transfusions. In addition to providing inadequate resuscitation, salvaged red blood cells can increase the rate of complications, including postoperative electrolyte abnormalities, thrombocytopenia, anemia, and coagulopathy.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。

↑